Spatial Heterogeneity of PD-L1 Expression as a Biomarker for Third-Generation EGFR-TKI Response in Advanced EGFR-Mutant NSCLC. Zhang Y, Xu Y, Jin H, Liu T, et al. Cancer Sci 2025;116:1648-1660.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang Y, Xu Y, Jin H, Liu T, et al. Spatial Heterogeneity of PD-L1 Expression as a Biomarker for Third-Generation EGFR-TKI Response in Advanced EGFR-Mutant NSCLC. Cancer Sci 2025;116:1648-1660.
PMID: 40102299